The promise and reality of cancer gene therapy

[1] INTRATUMORAL INJECTION OF AN ADENOVIRUS EXPRESSING INTERLEUKIN-2 INDUCES REGRESSION AND IMMUNITY IN A MURINE BREAST-CANCER MODEL [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) : 8522 - 8526

[2] DEVELOPMENT OF ANTITUMOR IMMUNITY FOLLOWING THYMIDINE KINASE-MEDIATED KILLING OF EXPERIMENTAL BRAIN-TUMORS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) : 4348 - 4352

[3] An adenovirus mutant that replicates selectively in p53-deficient human tumor cells [J]. SCIENCE, 1996, 274 (5286) : 373 - 376

[4] Bookstein R, 1996, SEMIN ONCOL, V23, P66

[5] Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12 [J]. HUMAN GENE THERAPY, 1996, 7 (16) : 1995 - 2002

[6] Brand K, 1997, CANCER GENE THER, V4, P9

[7] REGRESSION OF ESTABLISHED MACROSCOPIC LIVER METASTASES AFTER IN-SITU TRANSDUCTION OF A SUICIDE GENE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) : 7024 - 7028

[8] Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) : 11302 - 11306

[9] TUMOR IMMUNOGENICITY DETERMINES THE EFFECT OF B7 COSTIMULATION ON T-CELL-MEDIATED TUMOR-IMMUNITY [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) : 523 - 532

[10] COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J]. CELL, 1992, 71 (07) : 1093 - 1102

[1] INTRATUMORAL INJECTION OF AN ADENOVIRUS EXPRESSING INTERLEUKIN-2 INDUCES REGRESSION AND IMMUNITY IN A MURINE BREAST-CANCER MODEL [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) : 8522 - 8526

[2] DEVELOPMENT OF ANTITUMOR IMMUNITY FOLLOWING THYMIDINE KINASE-MEDIATED KILLING OF EXPERIMENTAL BRAIN-TUMORS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) : 4348 - 4352

[3] An adenovirus mutant that replicates selectively in p53-deficient human tumor cells [J]. SCIENCE, 1996, 274 (5286) : 373 - 376

[4] Bookstein R, 1996, SEMIN ONCOL, V23, P66

[5] Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12 [J]. HUMAN GENE THERAPY, 1996, 7 (16) : 1995 - 2002

[6] Brand K, 1997, CANCER GENE THER, V4, P9

[7] REGRESSION OF ESTABLISHED MACROSCOPIC LIVER METASTASES AFTER IN-SITU TRANSDUCTION OF A SUICIDE GENE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) : 7024 - 7028

[8] Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) : 11302 - 11306

[9] TUMOR IMMUNOGENICITY DETERMINES THE EFFECT OF B7 COSTIMULATION ON T-CELL-MEDIATED TUMOR-IMMUNITY [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) : 523 - 532

[10] COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J]. CELL, 1992, 71 (07) : 1093 - 1102